ImmunoTargets and Therapy
Last updated ISSN 2253-1556
ImmunoTargets and Therapy is published by Dove Medical Press in medicine. It is open access. The article processing charge is $2,320.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close ImmunoTargets and Therapy is — and show you journals like it.
What it publishes
Recent work in ImmunoTargets and Therapy concentrates on these topics, taken from its published record rather than from its own description:
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Immune cells in cancer
- Monoclonal and Polyclonal Antibodies Research
- Ferroptosis and cancer prognosis
- T-cell and B-cell Immunology
- Hepatocellular Carcinoma Treatment and Prognosis
- Immune Response and Inflammation
Key facts
| Publisher | Dove Medical Press |
|---|---|
| ISSN | 2253-1556 |
| Subject area | Medicine |
| Access | Open access |
| Article processing charge | $2,320 |
| Indexed in | Web of Science — Emerging Sources Citation Index · Scopus · DOAJ |
| Articles published | 362 |
| Publishing since | 1962 |
| Journal website | www.dovepress.com/immunotargets-and-therapy-journal |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like ImmunoTargets and Therapy
Other established journals in medicine, if this one is not the right home for your paper: